Crossover Trial of the Effect of a High-Fat Meal on the PK of Oral CHR 2797 in Healthy Male Subjects

计划入组 18 人 · 首次发布于 2012 年 7 月 11 日

A Study of the Safety and Tolerability of the Addition of CHR-2797 to Paclitaxel in Patients With Advanced or Refractory Tumours

计划入组 23 人 · 首次发布于 2008 年 8 月 19 日

Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours

计划入组 40 人 · 首次发布于 2008 年 6 月 16 日

CHR-27

CHR-101

CHR-3

Chr. Hansen A/S

Denmark

Nito Bedriftsgruppe, GE Healthcare Lindesnes Fabrikker

Norway

Centre Hospitalier Régional de la Citadelle

Belgium

Dawn Health Secures €11.5 Million to Expand Pharma-Focused Digital Health Platform

NFKB1 Haplotype Predicts Improved Response to Ropeginterferon Alfa-2b in PV and ET

Denovo Biopharma Partners with Orygen for Phase 2 Trial of Novel Glutamate-Targeting Drug in Early Psychosis